Second-line treatment for advanced NSCLC without actionable mutations: is immunotherapy the ‘panacea’ for all patients?

by Alessandro Morabito
Published 2018-02-01

Small Cell Lung Cancer: A New Era Is Beginning?

by Alessandro Morabito, Christian Rolfo
Published 2021-05-01

Underground Pumped Storage Hydropower Case Studies in Belgium: Perspectives and Challenges

by Alessandro Morabito, Jan Spriet, Elena Vagnoni, Patrick Hendrick
Published 2020-08-01

Title not available

by Adolfo Favaretto, Francesco Grossi, Alessandro Morabito, Roberto Ravasio
Published 2017-07-01

Costs of adverse events associated with afatinib, erlotinib, and gefitinib first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutations

by Adolfo Favaretto, Francesco Grossi, Alessandro Morabito, Roberto Ravasio
Published 2017-08-01

Promising Role of Circulating Tumor Cells in the Management of SCLC

by Antonella De Luca, Marianna Gallo, Claudia Esposito, Alessandro Morabito, Nicola Normanno
Published 2021-04-01

Focus on Nintedanib in NSCLC and other tumors

by Anna Manzo, Guido Carillio, Agnese Montanino, Raffaele Costanzo, Claudia Sandomenico, Gaetano Rocco, ALESSANDRO MORABITO
Published 2016-12-01

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma

by Diego Cortinovis, Paolo Bidoli, Stefania Canova, Francesca Colonese, Maria Gemelli, Maria Luisa Lavitrano, Giuseppe Luigi Banna, Stephen V. Liu, Alessandro Morabito
Published 2021-03-01

Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls

by Riziero Esposito Abate, Daniela Frezzetti, Monica Rosaria Maiello, Marianna Gallo, Rosa Camerlingo, Antonella De Luca, Rossella De Cecio, Alessandro Morabito, Nicola Normanno
Published 2020-12-01

Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation.

by Rosa Camerlingo, Roberta Miceli, Laura Marra, Giuseppina Rea, Igea D'Agnano, Marta Nardella, Roberta Montella, Alessandro Morabito, Nicola Normanno, Virginia Tirino, Gaetano Rocco
Published 2019-01-01

Angiogenesis Inhibitors in NSCLC

by Anna Manzo, Agnese Montanino, Guido Carillio, Raffaele Costanzo, Claudia Sandomenico, Nicola Normanno, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Perrone, Gaetano Rocco, Alessandro Morabito
Published 2017-09-01

Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

by Ernesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, Flaviano Di Paola, Monica Cantile, Sabrina Chiara Cecere, Sandro Pignata, Alessandro Morabito, Raffaele Costanzo, Massimo Di Maio, Francesco Perrone
Published 2016-01-01

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy

by Angela Mauriello, Carmen Manolio, Beatrice Cavalluzzo, Antonio Avallone, Marco Borrelli, Alessandro Morabito, Emanuele Iovine, Angela Chambery, Rosita Russo, Maria Lina Tornesello, Franco M. Buonaguro, Maria Tagliamonte, Luigi Buonaguro
Published 2020-01-01

Surgery in Small-Cell Lung Cancer

by Nicola Martucci, Alessandro Morabito, Antonello La Rocca, Giuseppe De Luca, Rossella De Cecio, Gerardo Botti, Giuseppe Totaro, Paolo Muto, Carmine Picone, Giovanna Esposito, Nicola Normanno, Carmine La Manna
Published 2021-01-01

Detection of EGFR Mutations by TaqMan Mutation Detection Assays Powered by Competitive Allele-Specific TaqMan PCR Technology

by Cristin Roma, Claudia Esposito, Anna Maria Rachiglio, Raffaella Pasquale, Alessia Iannaccone, Nicoletta Chicchinelli, Renato Franco, Rita Mancini, Salvatore Pisconti, Antonella De Luca, Gerardo Botti, Alessandro Morabito, Nicola Normanno
Published 2013-01-01

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

by Glenwood D. Goss, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassilis Georgoulias, Dolores Isla, Alessandro Morabito, Young J. Min, Andrea Ardizzoni, Shaun Bender, Agnieszka Cseh, Enriqueta Felip
Published 2021-07-01

Gefitinib in Non Small Cell Lung Cancer

by Raffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, Guido Carillio, Agnese Montanino, Gennaro Daniele, Pasqualina Giordano, Jane Bryce, Gianfranco De Feo, Massimo Di Maio, Gaetano Rocco, Nicola Normanno, Francesco Perrone, Alessandro Morabito
Published 2011-01-01

Angiogenesis Inhibitors in Small Cell Lung Cancer

by Agnese Montanino, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Vincenzo Sforza, Raffaele Costanzo, Claudia Sandomenico, Gerardo Botti, Maria C. Piccirillo, Priscilla Cascetta, Giacomo Pascarella, Carmine La Manna, Nicola Normanno, Alessandro Morabito
Published 2021-05-01

Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC

by Federica Zito Marino, Gerardo Botti, Gabriella Aquino, Stefano Ferrero, Gabriella Gaudioso, Alessandro Palleschi, Danilo Rocco, Rosario Salvi, Maria Carolina Micheli, Pietro Micheli, Alessandro Morabito, Gaetano Rocco, Antonio Giordano, Rossella De Cecio, Renato Franco
Published 2020-07-01

Clinical trials and drug cost savings for Italian health service

by Francesca D’Ambrosio, Gianfranco De Feo, Gerardo Botti, Arturo Capasso, Sandro Pignata, Piera Maiolino, Maria Triassi, Antonio Nardone, Franco Perrone, Michela Piezzo, Antonio Maria Grimaldi, Ida Palazzo, Immacolata De Stasio, Roberta D’Aniello, Alessandro Morabito, Giacomo Pascarella
Published 2020-11-01